Long-Term Safety and Efficacy of HSK39004 Inhalation Suspension in COPD

NCT07634367 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Interventions

DRUG: HSK39004 Inhalation Suspension

Sponsor

Haisco Pharmaceutical Group Co., Ltd.